These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3974347)

  • 41. Blood levels following oral administration of theophylline preparations.
    Jackson RH; Garrido R; Silverman HI; Salem H
    Ann Allergy; 1973 Sep; 31(9):413-9. PubMed ID: 4725597
    [No Abstract]   [Full Text] [Related]  

  • 42. Theophylline levels in patients receiving a controlled-release aminophylline preparation (Phyllocontin Continus tablets).
    Friend JA
    J Int Med Res; 1979; 7 Suppl 1():67-9. PubMed ID: 437310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Monitoring serum concentrations of theophylline during aminophylline infusion therapy].
    Prazáková J; Vondra V
    Cas Lek Cesk; 1985 Oct; 124(43):1332-5. PubMed ID: 4084951
    [No Abstract]   [Full Text] [Related]  

  • 44. [Retard theophylline in the treatment of asthma].
    Suskovic S; Jurcic B; Varga T; Furlan J
    Plucne Bolesti; 1986; 38(3-4):270-2. PubMed ID: 3588750
    [No Abstract]   [Full Text] [Related]  

  • 45. A steady state comparison of three theophylline formulations in adult stable asthmatics.
    Subramaniam S; Dhand R; Garg SK; Sharma PL
    Indian J Med Res; 1988 May; 87():509-15. PubMed ID: 3169909
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral fenoterol versus sustained release theophylline in adult asthmatics.
    Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of long-term oral administration of a sustained release theophylline preparation in children with chronic asthma.
    Cantani A; Businco E; Businco L; Solano A; Calabretta C
    Allergol Immunopathol (Madr); 1983; 11(1):11-4. PubMed ID: 6858803
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safe and effective use of sustained-release and intravenous theophylline.
    Boggs PB
    Compr Ther; 1982 Mar; 8(3):17-21. PubMed ID: 7067393
    [No Abstract]   [Full Text] [Related]  

  • 49. [The clinical effect of sustained-release theophylline (Theo-Dur) for asthmatic children and serum theophylline level (author's transl)].
    Masaki T; Sekine H; Nagakura T; Iikura Y; Tomita Y; Asano T; Kajita T; Seo K
    Arerugi; 1981 Apr; 30(4):190-6. PubMed ID: 7337549
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison at steady state of sustained-release theophylline tablets and capsules.
    Newth CJ; Isles AF
    J Asthma; 1982; 19(3):145-9. PubMed ID: 6749799
    [No Abstract]   [Full Text] [Related]  

  • 51. Sustained-release theophylline. Pharmacokinetic and therapeutic comparison of two preparations.
    Menendez R; Kelly HW; Howick J; McWilliams BC
    Am J Dis Child; 1983 May; 137(5):469-73. PubMed ID: 6846276
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
    Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
    Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparative effect of theophylline and aminophylline on theophylline blood concentrations and peripheral blood eosinophils in patients with asthma.
    Kato M; Tatsuta H; Okada K; Sakamoto K; Morita H
    Drugs Exp Clin Res; 2001; 27(2):83-8. PubMed ID: 11392058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of Nuelin-SR 250 mg in asthmatic children: a new sustained-release theophylline.
    Mitchell EA; Liang AY
    N Z Med J; 1980 Aug; 92(665):91-3. PubMed ID: 6933343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Symptoms and peak expiratory flow rate: response to a slow release theophylline preparation.
    Ho TF; Ngiam TE; Koh PK
    Singapore Med J; 1983 Oct; 24(5):280-4. PubMed ID: 6669991
    [No Abstract]   [Full Text] [Related]  

  • 56. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
    Zeidman A; Gardyn J; Fradin Z; Fink G; Mittelman M
    Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ; Demers L; Esler V; Field E
    Clin Ther; 1981; 4(4):252-62. PubMed ID: 7332913
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bioavailability of theophylline from a sustained-release aminophylline formulation (Euphyllin retard tablets)--plasma levels after single and multiple oral doses.
    Schuppan D; Molz KH; Staib AH; Rietbrock N
    Int J Clin Pharmacol Ther Toxicol; 1981 May; 19(5):223-7. PubMed ID: 7251238
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained-release theophylline therapy in Thai asthmatic children.
    Tuchinda M; Habanananda S; Srimaruta N; Chaichanwathanakul K; Geadsomnuig S
    J Med Assoc Thai; 1985 Feb; 68(2):81-6. PubMed ID: 4009090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.